ENHD yields 4210.53% · JNJ yields 2.14%● Live data
📍 ENHD pulled ahead of the other in Year 1
Combined, ENHD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENHD + JNJ for your $10,000?
Energroup Holdings Corporation, through its subsidiaries, produces, packs, sells, markets, and distributes fresh pork and processed meat products in the People's Republic of China and the Russian Federation. Its activities include acquiring, slaughtering, and packaging of pork; and processing of raw and cooked meat products. The company's products comprise fresh pork meat; frozen fresh meat, including smoked pork, ham, and roasts; and frozen fresh byproducts, such as pig's liver, stomach, intestine, head, and hoof products. It also offers prepared seafood products, such as fish sausage and shellfish sausage, which are made from fish, shrimp, and other varieties of seafood. Energroup Holdings Corporation serves city and town households, canteens and restaurants, and food processing companies. It offers its products under the Chuming name through its dealership distribution network, sales force, and resellers. The company was founded in 1999 and is headquartered in Dalian City, the People's Republic of China.
Full ENHD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.